SONN - Sonnet BioTherapeutics GAAP EPS of -$18.14 beats by $9.99 revenue of $0.15M in-line
2023-12-14 16:47:44 ET
More on Sonnet BioTherapeutics
- Seeking Alpha’s Quant Rating on Sonnet BioTherapeutics
- Historical earnings data for Sonnet BioTherapeutics
- Financial information for Sonnet BioTherapeutics
For further details see:
Sonnet BioTherapeutics GAAP EPS of -$18.14 beats by $9.99, revenue of $0.15M in-line